CHKD doctor and her kids get involved with pediatric Pfizer vaccine trials

Pfizer is expected to file safety and efficacy data with the FDA in early October for ages 5 to 11 and for younger children in November.

VIRGINIA, USA – “I encourage my children to always get out there and find things that can move us forward and move our community forward,” said pediatrician Dr. Theresa Broderick, Children’s Hospital of The King’s Daughters (CHKD). She has a 13- and 14-year-old who is enrolled in a Pfizer vaccine trial.

They started the procedure in January.

“They were very excited to be a part of the science in the future,” she said.

One received the vaccine, the other a placebo. But both are now vaccinated. They will be followed in the study until 2023.

“To protect themselves, their parents, grandparents, teachers, everyone in the community,” said Dr. Broderick.

dr. Broderick now told 13News that she is very impressed with the process, “in terms of checking up on the kids, calling, texting.”

dr. Broderick also has a 1-year-old and a 10-year-old ready to participate, “but we’re on the waiting list because their first places were full.”

They applied through the Virginia Research Center in the Richmond area.

dr. Raymond Decker told 13News Now families travel from areas like Hampton Roads and states like New Jersey and North Carolina.

He estimates that 90% of the pediatric vaccine study participants are infants or children of doctors or medical professionals.

“That’s the biggest endorsement of whether or not to get this vaccine,” he said.

dr. Decker wants to assure people that they take this research seriously.

“If we say this in terms of a baseball game, we’ve been throwing no-hitters since August 10 last year. This is a good, clean study,” he said.

As the studies for the younger age groups continue, Dr. Decker encourages vaccination for those who qualify. That is now, ages 12 and up.

And in a virtual town hall Thursday night, two of CHKD’s top medical experts answered questions to try to separate COVID fact from fiction.

“Normally it takes years to get the right funding and to get the right approvals. That part was accelerated,” said CHKD medical director Dr. Doug Mitchell. “But the trials, the science, no shortcuts had been taken.”

The doctors explained the vaccine’s critical role in relieving congested hospital systems.

Lately, sick patients are getting younger and younger.

The experts also mentioned that while breakthrough cases are possible, the vaccines are still very effective.

“We protect you from hospitalization and death. The same should be true for your children,” says CHKD Pediatric Infectious Disease Specialist Dr. Laura Sass. “I want to reassure people that I vaccinated my own children and I wouldn’t tell you to vaccinate your own children if I didn’t think it was safe.”

If you missed the webinar, CHKD said the recording will be posted on their website.

Comments are closed.